Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer Patients

PURPOSE: The combination of gemcitabine and cisplatin (GP) has been shown to be safe and efficacious for patients with metastatic breast cancer (MBC), pretreated with anthracyclines and taxanes. We assessed the efficacy and safety of weekly low-dose GP in patients with MBC. METHODS: We collected cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Sun, Park, In Hae, Lee, Keun Seok, Ro, Jungsil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278052/
https://www.ncbi.nlm.nih.gov/pubmed/25548581
http://dx.doi.org/10.4048/jbc.2014.17.4.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278052/
https://www.ncbi.nlm.nih.gov/pubmed/25548581
http://dx.doi.org/10.4048/jbc.2014.17.4.339

Ejemplares similares